NewBiotics
San Diego
About NewBiotics
NewBiotics transforms drug resistances into therapeutic advantages. It focuses on the discovery and development of drug molecules that leverage the cycle of drug resistance in both cancer and infectious diseases. NewBiotics is a U.S.-based company that was founded in 1997 and the company was acquired by Celmed Biosciences on June 7, 2004.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $21.9M
- Funding stage: M&A
- Last round: Series E (Apr 2004)
- Website: newbiotics.com
Industries & Categories
Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/newbiotics-2881189 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.